Erythromycin-d6

Modify Date: 2024-01-07 10:21:24

Erythromycin-d6 Structure
Erythromycin-d6 structure
Common Name Erythromycin-d6
CAS Number 959119-25-6 Molecular Weight 739.964
Density 1.2±0.1 g/cm3 Boiling Point 818.4±65.0 °C at 760 mmHg
Molecular Formula C37H61D6NO13 Melting Point N/A
MSDS N/A Flash Point 448.8±34.3 °C

 Use of Erythromycin-d6


Erythromycin-d6 is the deuterium labeled Erythromycin. Erythromycin is a macrolide antibiotic produced by actinomycete Streptomyces erythreus with a broad spectrum of antimicrobial activity. Erythromycin acts by binding to bacterial 50S ribosomal subunits and inhibits RNA-dependent protein synthesis by blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid[1].

 Names

Name (3R,4S,5R,6R,7R,9R,11R,12S,13S,14R)-6-{[(2S,3R,4S,6R)-4-{Bis[(2H3)methyl]amino}-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)

 Erythromycin-d6 Biological Activity

Description Erythromycin-d6 is the deuterium labeled Erythromycin. Erythromycin is a macrolide antibiotic produced by actinomycete Streptomyces erythreus with a broad spectrum of antimicrobial activity. Erythromycin acts by binding to bacterial 50S ribosomal subunits and inhibits RNA-dependent protein synthesis by blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid[1].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Gribble MJ, et al. Erythromycin. Med Clin North Am. 1982 Jan;66(1):79-89.

[3]. Nakornchai S, et al. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 2006 Dec;100(3):185-91. Epub 2006 Nov 28.

[4]. K Hamada, et al. Antitumor Effect of Erythromycin in Mice. Chemotherapy

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 818.4±65.0 °C at 760 mmHg
Molecular Formula C37H61D6NO13
Molecular Weight 739.964
Flash Point 448.8±34.3 °C
Exact Mass 739.498901
LogP 2.83
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.535